The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
A care worker and special constable has been jailed for attempted murder after lacing her colleagues' drinks with bleach.
A woman was attacked and killed by fire ants as she sat planning the funeral of her mother, who died the day before.
A group of primary school children witnessed a 17-year-old boy getting stabbed in the street, according to reports.